Safety and Immunogenicity of ChAd63 RH5 and MVA RH5 in Adults, Young Children and Infants Living in Tanzania

NCT03435874 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL: ChAd63 RH5
BIOLOGICAL: MVA RH5
BIOLOGICAL: Rabies Vaccine

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]